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1. Introduction 
Ferrochelatase, the enzyme which catalyses the in- 
corporation of Fe(H) into porphyrins has been pre- 
pared from a variety of tissues [l-3] . However, in vi- 
tro studies with ferrochelatase extracts have shown 
that cobalt-porphyrins are readily formed. Further- 
more, substrate specificity for this enzyme system 
has been tested using various divalent metals and por- 
phyrin derivatives, and cobalt was reported to be in- 
serted into deuteroporphyrin as rapidly as iron, while 
cobalt was incorporated into protoporphyrin at ap- 
proximately one fourth the rate of iron [4]. 
The in vivo incorporation of radioactive manganese 
into human erythrocytes as evidence for the biosyn- 
thesis of manganese porphyrins has been reported [5] 
In this paper, gel filtration, atomic absorption spec- 
troscopy along with radiochemical techniques were 
employed and data is presented to suggest the in vivo 
synthesis of cobalt porphyrins in rats. 
2. Materials and methods 
2.1. Animals 
In addition to standard laboratory diets and water, 
adult male rats (weight approximately 300 g)were 
given one ml daily intraperitoneal injections of 
1 mM CoC12 in saline tagged with cobalt -58. This 
dose (59 c(g cobalt per day) was given to all animals; 
however ats l-3 (see fig. 1) were removed from the 
cobalt schedule three weeks before they were sacri- 
ficed after having received the daily injections for 10 
weeks. Animals No. 4-6 (fig. 1) received the the in- 
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jections continuously for 12 weeks and until the day 
they were sacrificed. In other experiments injections 
were continued for longer periods. Blood samples 
were collected by cardiac punctures. 
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Fig. 1. Radiochemical data for cobalt deposition in rat cardic 
tissue. 
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2.2. Radioautography 
Heart tissues were removed, quick frozen, thin 
sliced, placed on X-ray type photographic paper and 
radioautography carried out at 5’. The radioauto- 
graphs were further analyzed with a densitometer and 
the mean-density readings per unit area is given in fig. 
1B. The entire hearts were wet-ashed after the radio- 
autograph process and total cobalt was determined by 
liquid scintillation counting. In fig. 1A the deposition 
of cobalt per gram of wet tissue is computed. 
2.3. Preparation of red cell hemolysate and hemoglo- 
bin 
Plasma was removed by centrifugation and red 
blood cells washed three times with 1.2% sodium 
chloride solution and the supematant liquid aspirated. 
In some experiments, packed cells were hemolyzed 
according to the method of Hinson and McMeekin 
[6] in which case hemoglobin crystals were obtained. 
In other experiments, the cells were hemolyzed by 
the addition of l-2 volumes of water and 0.4 volumes 
of toluene and stroma and cell debris separated from 
the hemoglobin solution by centrifugation. This stro 
ma free hemoglobin solution was then filtered through 
absorbent cotton. Hemoglobin was also isolated from 
hearts by homogenizing minced tissues in a Potter 
Elvehjem type homogenizer. The aqueous hemoglobin 
extract was then treated in a manner similar to that 
removed from red blood cells. 
2.4. Cobalt analysis 
A Techtron AA-S Atomic Absorption Spectro- 
meter was used in experiments where the total cobalt 
concentration was determined. 
3. Results 
Blood cells collected at designated intervals follow- 
ing injection of cobalt chloride were hemolized and 
assayed for %Zo. The fact that activity increased 
with time up to approximately 5 to 6 weeks before 
reaching aplateau suggests he saturation of a cobalt 
“pool” which could correspond to a threshold con- 
centration of a specific metabolite such as a blood 
porphyrin. This 58Co activity could not be removed 
by dialysis. 
After animals had received 5*Co injections for two 
months, an aliquot of cell hemolysate was prepared 
and was passed through a Sephadex G-50 column. 
Fractions under the hemoglobin peak were counted 
and the %o peak concided with the hemoglobin 
peak to again suggest a “cobalt porphyrin” protein. 
Radioautographic techniques were used to demon- 
strate the accumulation of %o in cardiac tissue. Ra- 
dioautographs included exposures through three sec- 
tion planes of the hearts: tranverse; frontal and sagit- 
tal. 58Co appeared to be uniformly dispersed through 
these sections in a homogeneous fashion showing 
little or no evidence of site localization and approxi- 
mately fifty per cent remained after animals were 
removed from the cobalt schedule. Results from den- 
sitometer tracings of the radioautographs are given in 
fq. lB, and the total cobalt content of the hearts is 
given in fig. 1A. In another experiment, cobalt levels 
in heart extracts from animals receiving cobalt injec- 
tions for several months ranged from 1 X lo5 to 
5 X 10J M. No cobalt was detectable in tissue ex- 
tracts from control animals. 
4. Discussion 
The results how that a nondialysible cobalt com- 
pound appears in erythrocytes and accumulates in
cardiac tissue following 2-3 months daily injections 
of cobalt chloride. The deposition of cobalt in heart 
tissue could be due to its role as a “substituted” con- 
stitutent in certain hemoproteins, ince hemoglobin 
extracts of these tissues contained the cobalt com- 
pound as was demonstrated by atomic absorption, 
radiochemical nd gel filtration experiments. The 
time course of the appearance of 58Co in erythrocytc ! 
resemble that which followed the incorporation of M 
(II) into human erythrocytes [5] . In vitro experi- 
ments of Johnson and Jones [4] showed that the 
rate of formation of metalloporphyrins was sensitive 
to the type of porphyrin; that is, both cobalt and iron 
were rapidly inserted into deuteroporphyrins while 
cobalt was less readily inserted into protoporphyrins 
than iron. Thus, it would seem that metalloporphyrin 
forming enzymes may show greater specificity toward 
the porphyrin than toward the metal. 
In nature the important porphyrins occurring free 
(uncomplexed with metals) are protoporphyrin and 
the isomers of uro- and coproporphyrins [7] and the 
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hems (iron complexes of porphyrins) are unquesti- References 
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_-. 
onably the most important biologically active hemo- 
protein. However, minute amounts of other porphyrins 
could be present, in which case, cobalt-porphyrins 
could perhaps be synthesized in very small, yet de 
tectable quantities. 
These observations are of special interest in view of 
the fact that coprotoporphyrin is used in cancer the 
motherapy. Its cytotoxic activity is assumed to be at- 
tributable to its affmity to lipoproteins involved in 
membraneous structures of tumor cells [7,8]. How- 
ever, the mechanisms of these compounds with regard 
to direct effects on various types of tumor cells is 
not fully understood. 
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